The Evaluation and comparison of the effects and complications of escitalopram and citalopram on depression in patients with chronic renal failure undergoing hemodialysis referring to university hospitals in Yazd
- سال انتشار: 1404
- محل انتشار: مجله بین المللی پزشکی رضوی، دوره: 13، شماره: 2
- کد COI اختصاصی: JR_RIJO-13-2_004
- زبان مقاله: انگلیسی
- تعداد مشاهده: 87
نویسندگان
Department of Psychiatry, Research Center of Addiction and Behavioral Sciences,Shahid Sadoughi, University of Medical Sciences,Yazd, Iran
Department of Psychiatry, Research Center of Addiction and Behavioral Sciences,Shahid Sadoughi, University of Medical Sciences,Yazd, Iran
Department of Psychiatry, Research Center of Addiction and Behavioral Sciences,Shahid Sadoughi, University of Medical Sciences,Yazd, Iran
Deparment of Internal Medicine, Shahid Sadoughi, University of Medical Sciences,Yazd, Iran
Deparment of Internal Medicine, Shahid Sadoughi, University of Medical Sciences,Yazd, Iran
چکیده
Background: This study compared the efficacy of citalopram and escitalopram in treating depression among patients with chronic renal failure undergoing hemodialysis. Methods: This double-blind clinical trial was conducted on ۴۶ patients diagnosed with Major Depressive Disorder (MDD) and chronic renal failure undergoing hemodialysis. The depression rating scale used was the Hamilton Depression Questionnaire. Patients were randomly assigned to two groups: the citalopram group (n=۲۴) and the escitalopram group (n=۲۲), and they underwent a ۶-week treatment. Drug side effects were assessed and recorded at the conclusion of the study period. Demographic variables such as age, gender, duration of depression, duration of dialysis, marital status, and educational level were also collected. The data were then analyzed using statistical tests. Results: There was no significant difference between the two groups in terms of gender distribution (p=۰.۴۰۴), marital status (p=۰.۱۵۵) and educational level (p=۰.۳۲۹). Also, no significant difference was found between the mean variables: age (p=۰.۴۷۸), duration of depression (p=۰.۴۸۵) and duration of dialysis (p=۱.۰۰۰). There was no significant difference between the mean depression score before treatment in the two groups (p = ۰.۱۰۷) and after treatment in the two groups (p = ۰.۴۱۲). But the mean depression score after treatment compared to before treatment was significantly lower in both groups (p=۰.۰۰۰). Also, no significant difference was found between the frequency of drug side effects in the two groups (p=۰.۲۹۲). Conclusion: According to results, it can be concluded that both drugs have been shown to improve depression in in patients with chronic renal failure undergoing hemodialysis and are not different in their efficacy and side effects.Trial registration: IRCT۲۰۲۰۰۳۰۴۰۴۶۶۹۸N۱کلیدواژه ها
Chronic Kidney failure, Citalopram Depression, Hemodialysisاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.